← FDA Drug Approvals (Drugs@FDA)

OPDUALAG

BLA · Biologics License Application · Sponsor: BRISTOL MYERS SQUIBB · Approved 2022-03-18

Drug application

FDA Application #

BLA761234

Application type

Biologics License Application

Brand name

OPDUALAG

Generic name

NIVOLUMAB AND RELATLIMAB-RMBW

Active ingredients

NIVOLUMAB; RELATLIMAB-RMBW

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BRISTOL MYERS SQUIBB

Manufacturer

E.R. Squibb & Sons, L.L.C.

First approval

2022-03-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown